Humanized immunoglobulins and their production and use
CA 2006865 C · Owner: Selick, Harold E. · Inventors: Queen, Cary L.; Selick, Harold E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel methods for designing humanized, immunoglobulins having one or more complementarity determining regions (CDR's) from a donor immunoglobulin and a framework region from a human immunoglobulin comprising first comparing the framework or variable region amino acid sequence of the donor immunoglobulin to corresponding sequences in a collection of human immunoglobulin chains and, selecting as the human immunoglobulin one of the more homologous sequences from the collection. Each humanized immunoglobulin chain may comprise about 3 or more amino acids from the donor immunoglobulin in addition to the CDR's usually at least one of which is immediately adjacent to a CDR in the donor …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 28, 1989 and granted August 20, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 28, 2009.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 28, 2011.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.